Host RNA Profiles to Detect Infections in Young Infants

Sepsis Clinical Trial

— CHILD_YIC  

Official title:

Host RNA Profiles to Detect Infections in Young Infants

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04823026
• Other study ID #: H-18065635-YIC
• Status: Completed
• Start date: May 15, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: December 2022
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study seeks to identify and test host RNA expression profiles as markers for infections in young infants. Preliminary studies have shown high sensitivity and specificity for the discrimination of bacterial from non-bacterial infections in children, but the method has only been investigated in a limited number of young infants. The study aims to include 65 young infants with serious bacterial infections. The samples will be analysed by RNA sequencing. New diagnostic tools may help reduce unnecessary antibiotic treatment, antibiotic resistance, side-effects, hospitalisation and invasive procedures.

Description:

Background: Infections in young infants is a challenge as 1) it is often not possible to distinguish serious bacterial infection (SBI) from viral infection by clinical appearance alone, 2) a causative organism is often not identified and 3) due to relatively low sensitivity and specificity of current biomarkers. The consequence is overtreatment with antibiotics being prescribed to as many as 50% of febrile young infants presenting to emergency departments. However, the majority of these children does not have a bacterial infection. Host RNA expression profiling has shown high sensitivity and specificity for discriminating bacterial from non-bacterial infections in preliminary studies of febrile young infants. Methods: A prospective multicentre observational study including young infants admitted and evaluated due to suspected infection at the 4 paediatric acute care units in the Capital Region of Denmark (Rigshospitalet, Hvidovre Hospital, Herlev Hospital, Nordsjællands Hospital - Hillerød). Whole blood will be collected in PAXgene blood RNA tubes and analysed by RNA sequencing at the Centre for Genomic Medicine, Rigshospitalet. Host RNA expression profiles will be identified in a discovery cohort and the diagnostic performance will be tested in a validation cohort. A control group of healthy and afebrile young infants will be included. Time frames: Patient recruiting: May 15th 2020 to February 28th 2022. Sample analysis (RNA sequencing): March 1st 2022 to August 31st 2022. Perspectives: New molecular-based diagnostic tools complementary to conventional methods may optimise infection management in young infants by improving early diagnostics and allowing early modification of antibiotic treatment. This will reduce antibiotic resistance, side effects, unnecessary hospitalisation and invasive procedures.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 152
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 3 Months

Eligibility

Inclusion Criteria:

1. age 0-3 months

2. admitted from home

3. suspected of infection

4. having routine blood sampling done

5. gestational age or corrected gestational age greater than or equal to 37+0

6. informed consent

Exclusion Criteria:

1. not possible to draw blood tests

2. withdrawal of consent

3. sampling >48 hours after admission

Related Conditions & MeSH terms

• Bacteremia
• Bacterial Infections
• Communicable Diseases
• Fever
• Infant, Newborn, Disease
• Infant, Newborn, Diseases
• Infections
• Meningitis
• Sepsis
• Urinary Tract Infections
• Viral Infection
• Virus Diseases

Locations

Country	Name	City	State
Denmark	Department of Paediatrics and Adolescent Medicine, Rigshospitalet	Copenhagen
Denmark	Department of Paediatrics and Adolescent Medicine, Herlev Hospital	Herlev
Denmark	Department of Paediatrics and Adolescent Medicine, Nordsjællands Hospital - Hillerød	Hillerød
Denmark	Department of Paediatrics, Hvidovre Hospital	Hvidovre

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Host RNA expression profiles	To identify specific host RNA expression profiles in whole blood in response to bacterial infections in young infants	21 months
Secondary	Application of known host RNA profiles	To test host RNA profiles published in other studies, e.g. based on the genes IFI44L and FAM89A	21 months
Secondary	Time study	To investigate the change in host RNA expression over time during an infection period	21 months